BUPROPION HYDROCHLORIDE (SR)
- Product NDC
- 70518-2648
- 11-digit product format
- 705182648
- Labeler code
- 70518
- Product ID
- 70518-2648_cc6deaba-8aa2-d8d0-e053-2a95a90a791c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206122
- Marketing category
- ANDA
- Marketing start
- 2020-03-24
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2648-0 | 70518264800 | 30 POUCH in 1 BOX (70518-2648-0) > 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-2648-1) | 30 pouch | 2020-03-24 | 0000-00-00 | No | No | Current |